...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

Actually Koo I have not really been paying attention at all. Have yet to check out the AGM. Figure I got a boat load of free shares and if something happens I will let it be a surprise as got enough disappointments with the other. Lol. 

CCD

Share
New Message
Please login to post a reply